参考文献/References:
[1] 朱志远，王海燕，吴波，等．冠心病患者血小板和淋巴细胞比值与冠脉斑块稳定性及预后的相关性[J]. 现代检验医学杂志,2019,34(4):112-115, 119.ZHU Zhiyuan,WANG Haiyan,WU Bo，et al.Correlation between ratio of platelet to lymphocyte withthe stability of coronary artery plaque and prognosisin patients with coronary heart disease [J] .Journal ofModern Laboratory Medicine, 2019,34(4):112-115,119.
[2] 王伟芳，杜薇，丁智超．RVv/LVv 和超声心动图在肺动脉高压诊断中的价值[J]. 中国现代医学杂志,2018,28(32):77-81.WANG Weifang,DU Wei,DING Zhichao. Rightventricular volume to left ventricular volume ratioand echocardiography in diagnosis of pulmonaryhypertension [J]. China Journal of Modern Medicine,2018, 28(32):77-81.
[3] 高建华，何颖辉．冠心病并发幽门螺杆菌感染患者血清HP 抗体谱特征与炎性因子水平相关性分析[J].现代检验医学杂志,2019,34(4):53-57.GAO Jianhua,HE Yinghui. Correlation analysis ofserum antibody spectrum and inflammatory factor levelin patients with coronary heart disease complicatedwith Helicobacter polori infection [J]. Journal ofModern Laboratory Medicine, 2019,34(4):53-57.
[4] 马苑真，董莉．动脉粥样硬化相关血清生物化学及分子生物学检测指标的最新研究进展[J]．现代检验医学杂志,2020,35(3):160-164.MA Yuanzhen,DONG Li. Recent advances in thedetection of serum biochemistry and molecular biologyof atherosclerosis [J].Journal of Modern LaboratoryMedicine,2020,35(3):160-164.
[5] REHMAN M B, GARCIA R, CHRISTIAENS L, etal. Power of resting echocardiographic measurementsto classify pulmonary hypertension patients accordingto European society of cardiology exercise testingrisk stratification cut-offs[J]. International Journal ofCardiology, 2018, 257: 291-297.
[6] LEVINE G N, BATES E R, BITTL J A, et al. 2016ACC/AHA guideline focused update on duration ofdual antiplatelet therapy in patients with coronaryartery disease: A report of the American College ofCardiology/American Heart Association Task Forceon Clinical Practice Guidelines.[J]. The Journal ofThoracic and Cardiovascular Surgery, 2016, 152(5) :1243-1275.
[7] 中华医学会心血管病学分会心力衰竭学组，中国医师协会心力衰竭专业委员会，中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]．中华心血管病杂志,2018, 46(10):760-789.Heart Failure Group of Chinese Society of Cardiologyof Chinese Medical Association, Chinese HeartFailure Association of Chinese Medical DoctorAssociation, Editorial Board of Chinese Journal ofCardiology. Chinese guidelines for the diagnosis andtreatment of heart failure 2018 [J]. Chinese Journal ofCardiovascular Research,2018, 46(10):760-789.
[8] 刘亚东，冯莉莉，王海晶，等．冠心病患者血清Lp-PLA2 与HCY 检测及其与冠状动脉病变程度的相关性分析[J]. 现代检验医学杂志,2018,33(6):83-87.LIU Yadong,FENG Lili,WANG Haijing,et al. Detectionof serum Lp-PLA2 and HCY in patients with coronaryheart disease and its correlation with the degreeof coronary artery disease[J]. Journal of ModernLaboratory Medicine,2018,33(6):83-87.
[9] 欧阳春, 韩振, 叶小强, 等. 冠心病患者ABCA1基因多态性及血清FABP3 水平联合检测与冠状动脉血管病变的相关性研究[J]. 现代检验医学杂志,2020,35(2):1-5, 11.OUYANG Chun,HAN Zhen,YE Xiaoqiang,et al.Correlation of ABCA1 gene polymorphism and serumFABP3 level with coronary artery disease in patientswith coronary heart disease [J]. Journal of ModernLaboratory Medicine, 2020, 35(2):1-5,11.
[10] 曹雅兰，向姝婷，王钰，等．射血分数保留心力衰竭患者无创血流动力学与超声心动图一年随访的对比研究[J]. 中国医师进修杂志,2020,43(8):691-695.CAO Yalan,XIANG Shuting,WANG Yu,et al. Comparativestudy of non-invasive hemodynamics and echocardiographyon heart failure with preserved ejectionfraction patients:one year follow-up [J]. Chinese Journalof Postgraduates of Medicine,2020,43(8):691-695.
[11] 程俊杰, 李静, 梁西强, 等. 非高密度脂蛋白胆固醇与冠心病患者心功能分级的相关性研究[J]. 现代检验医学杂志, 2016,31(3):43-47.CHENG Junjie ,LI Jing ,LIANG Xiqiang ,et al.Correlation between non high density lipoproteincholesterol and cardiac function in patients withcoronary heart disease [J].Journal of ModernLaboratory Medicine, 2016,31(3):43-47.
[12] 罗金，蓝柳萍．血液RDW,Hcy 和NEFA 水平联合检测在冠心病诊断中的应用[J]．现代检验医学杂志，2020,35(3):62-65, 80.LUO Jin,LAN Liuping. Application of combineddetection of blood RDW,Hcy and NEFA levels in thediagnosis of coronary heart disease [J]. Journal ofModern Laboratory Medicine,2020,35(3):62-65,80.
[13] 白金娥, 林小艳. 外周血NLR 与PLR 对急性肺梗死患者预后价值探析[J]. 现代检验医学杂志,2017,32(5):137-140, 144.BAI Jine,LIN Xiaoyan. Prognosis affects of neutrophilto lymphocyte ratio and platelet to lymphocyteratio of peripheral blood for patients with acute lunginfarction [J] .Journal of Modern Laboratory Medicine,2017,32(5):137-140,144.
[14] 张学铭，庄琦，杨梦慧，等. 四维超声心动图结合二维斑点追踪技术评价肺动脉高压患者右心功能和预后[J]. 中华心血管病杂志,2018,46(12):965-971.ZHANG Xueming,ZHUANG Qi,YANG Menghui,et al.Value of four-dimensional echocardiography combinedwith speckle tracking technique on the assessment ofright heart function and prognosis in patients with pulmonaryarterial hypertension [J]. Chinese Journal ofCardiology,2018,46(12):965-971.
[15] 戴学庆，涂秀，纪泽森．血液D-D,NT-proBNP 和Trop Ⅰ联合检测在急性胸痛症早期诊断中的价值[J]. 现代检验医学杂志,2018,33(4):115-118.DAI Xueqing,TU Xiu,JI Zesen. Value of combineddetection of blood D-D,NT-proBNP and Trop I inthe early diagnosis of acute chest pain [J]. Journal ofModern Laboratory Medicine,2018,33(4):115-118.
[16] 崔贞, 刘文. 慢性心力衰竭患者呋塞米治疗对血清NT-proBNP 水平的影响[J]. 现代检验医学杂志,2019,34(3):144-147.CUI Zhen,LIU Wen. Effects of furosemide in patientswith chronic heart failure on serum NT-proBNP [J].Journal of Modern Laboratory Medicine, 2019,34(3):144-147.
[17] 汪隆海, 陈启松, 夏芳, 等. 和肽素与大内皮素-1 及N 末端脑钠肽对心力衰竭的预后价值[J]. 现代检验医学杂志,2015,30(1):64-67, 71.WANG Longhai,CHEN Qisong,XIA Fang,et al.Prognostic value of copeptin ,big endothelin-1 andN-terminal pro-Brain natriuretic peptide in patients withchronic heart failure [J] .Journal of Modern LaboratoryMedicine,2015,30(1):64-67,71.
[18] 郭飞波．CypA，BNP，ET-1 浓度在老年慢性心衰患者中的表达及临床意义[J]. 现代检验医学杂志,2016,31(6):88-91.GUO Feibo. Expression characteristics and clinicalsignificance of CypA,BNP and ET-1 in elderly patientswith chronic heart failure [J].Journal of ModernLaboratory Medicine,2016,31(6):88-91.
[19] 王璐，李维娟，杨靖．血清NT-proBNP 和Cys-C 水平联合检测在心力衰竭诊断与分型中的应用[J]. 现代检验医学杂志,2018,33(6):91-94.WANG Lu,LI Weijuan,YANG Jing. Application ofcombined detection of serum NT-proBNP and Cys-Clevels in diagnosis and typing of heart failure [J]. Journalof Modern Laboratory Medicine,2018,33(6):91-94.
相似文献/References:
[1]韩瑞玲,李 艳,吴 薇.武汉地区冠心病患者氯吡格雷药物代谢相关基因CYP2C19的多态性分布分析[J].现代检验医学杂志,2015,30(03):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
HAN Rui-ling,LI Yan,WU Wei.Analysis of the Polymorphism Distribution of Clopidogrel Metabolism
Related Gene CYP2C19 in Patients with Coronary Artery Disease in Wuhan[J].Journal of Modern Laboratory Medicine,2015,30(04):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
[2]洪骏,王锋,印中鹏,等.冠心病患者血浆纤维蛋白原与脂蛋白相关磷脂酶A2水平[J].现代检验医学杂志,2015,30(05):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
HONG Jun,WANG Feng,YIN Zhong-peng,et al.Levels of Plasma Lipoprotein Associated Phospholipase A2
and Fibrinogen in Patients with Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2015,30(04):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
[3]赵佳a,姚创利a,左林,等.冠心病患者血清同型半胱氨酸对血脂和锰超氧化物歧化酶的影响[J].现代检验医学杂志,2015,30(05):44.[doi:10.3969/j.issn.1671-7414.2015.05.013]
ZHAO Jiaa,YAO Chuang-lia,ZUO Lin,et al.Effects of Homocysteine on Blood Lipid and Manganese Superoxide
Dismutase in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2015,30(04):44.[doi:10.3969/j.issn.1671-7414.2015.05.013]
[4]李 垚,杨 平.早发冠心病触珠蛋白水平及其在免疫调节中的作用研究[J].现代检验医学杂志,2015,30(01):98.[doi:10.3969/j.issn.1671-7414.2015.01.027]
LI Yao,YANG Ping.Role of Haptoglobin in the Immunomodulatory
in Patients with Premature Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2015,30(04):98.[doi:10.3969/j.issn.1671-7414.2015.01.027]
[5]张 蕾,陈 捷,陈玉婷.冠心病并发恶性肿瘤患者Ghrelin/obestatin比值变化及意义[J].现代检验医学杂志,2016,31(04):104.[doi:10.3969/j.issn.16717-414.2016.04.029]
ZHANG Lei,CHEN Jie,CHEN Yu-ting.Change and Significance of Ghrelin/Obestatin in Patients
with Coronary Heart Disease Complicated with Malignant Tumor[J].Journal of Modern Laboratory Medicine,2016,31(04):104.[doi:10.3969/j.issn.16717-414.2016.04.029]
[6]赵 佳,左 林,姚创利,等.冠心病患者血清同型半胱氨酸水平与氧化应激的关系研究[J].现代检验医学杂志,2016,31(05):27.[doi:10.3969/j.issn.1671-7414.2016.05.007]
ZHAO Jia,ZUO Lin,YAO Chuang-li,et al.Study on the Relationship between Serum Homocysteine Levels
and Oxidative Stress in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2016,31(04):27.[doi:10.3969/j.issn.1671-7414.2016.05.007]
[7]姚创利,黎 阳,鲁旭娟,等.超氧化物歧化酶及其同工酶和超敏C-反应蛋白与冠心病的关系[J].现代检验医学杂志,2016,31(05):73.[doi:10.3969/j.issn.1671-7414.2016.05.019]
YAO Chuang-li,LI Yang,LU Xu-juan,et al.Relationship of Superoxide Dismutase Isoenzyme and High
Sensitive C-Reactive Protein with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2016,31(04):73.[doi:10.3969/j.issn.1671-7414.2016.05.019]
[8]黄生金,郑利平,陆俊佳,等.广西地区壮族和汉族冠心病患者胱抑素C水平及其基因多态性的比较研究[J].现代检验医学杂志,2017,32(03):26.[doi:10.3969/j.issn.1671-7414.2017.03.007]
HUANG Sheng-jin,ZHENG Li-ping,LU Jun-jia,et al.Comparative Study of Cystatin C and Its Gene Polymorphism of Pati
ents
with Coronary Heart Disease between Zhuang and Han in Guangxi Region[J].Journal of Modern Laboratory Medicine,2017,32(04):26.[doi:10.3969/j.issn.1671-7414.2017.03.007]
[9]王跃帮,吴 娟,崔 倩,等.IL-6基因启动子区域-572C>G和-174G>C多态性与江苏宿迁汉族人群冠心病的相关性[J].现代检验医学杂志,2018,33(03):31.[doi:10.3969/j.issn.1671-7414.2018.03.010]
WANG Yue-bang,WU Juan,CUI Qian,et al.Association between Interleukin-6-572C>G
and -174G>C Gene Polymorphism in the Promoter Region
and Coronary Heart Disease of Han Population in Suqian of Jiangsu[J].Journal of Modern Laboratory Medicine,2018,33(04):31.[doi:10.3969/j.issn.1671-7414.2018.03.010]
[10]刘亚东,冯莉莉,王海晶,等.冠心病患者血清Lp-PLA2与HCY检测及其与冠状动脉病变程度的相关性分析[J].现代检验医学杂志,2018,33(06):83.[doi:10.3969/j.issn.1671-7414.2018.06.022]
LIU Ya-dong,FENG Li-li,WANG Hai-jing,et al.Detection of Serum Lp-PLA2 and HCY in Patients with Coronary Heart Disease and Its Correlation with the Degree of Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2018,33(04):83.[doi:10.3969/j.issn.1671-7414.2018.06.022]